ArticleThoracic cancer2020

Poor efficacy of anti-programmed cell death-1/ligand 1 monotherapy for non-small cell lung cancer patients with active brain metastases.

Takehiro Tozuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.